Home/Filings/4/0001062993-23-011815
4//SEC Filing

Melincoff Gwen A 4

Accession 0001062993-23-011815

CIK 0001267565other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:38 PM ET

Size

5.1 KB

Accession

0001062993-23-011815

Insider Transaction Report

Form 4
Period: 2023-05-18
Transactions
  • Award

    Common Stock

    2023-05-18+9,79244,775 total
Footnotes (1)
  • [F1]Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 18, 2024, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock.

Issuer

COLLEGIUM PHARMACEUTICAL, INC

CIK 0001267565

Entity typeother

Related Parties

1
  • filerCIK 0001614890

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:38 PM ET
Size
5.1 KB